In an information-overloaded environment, how can we make sure that the right cancer treatment finds the right patient?

Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.

AbbVie Inc.'s Q1 earnings highlight an 8.4% revenue boost, driven by Skyrizi & Rinvoq. Click for ABBV's market expansion, ...

Genomics company, Integrated DNA Technologies, is rewriting the future of genomics, pioneering new innovations in a bold move ...

April 15, 2025 (Investorideas.com Newswire) Investorideas.com ( www.investorideas.com ), a go-to platform for big investing ...

Gut Microbiota in Immuno-Oncology: A Practical Guide for Medical Oncologists With a Focus on Antibiotics Stewardship Bispecific antibodies (bsAbs) have emerged as a novel class of therapeutics, ...

Dextenza is not recommended for treating ocular itching with allergic conjunctivitis in children who require sedation for the insertion procedure. The Food and Drug Administration (FDA ...

A multi-institutional study led by Moffitt Cancer Center found that percutaneous hepatic perfusion using a melphalan hepatic delivery system may help patients with a rare eye cancer that has spread to ...

combating cancer by restricting blood supply to the tumour, it said. With this approval, Biocon Biologics has expanded its oncology portfolio in the US, which also includes Ogivri and Fulphila.

Sen. John Kennedy (R-La.) criticized President Trump’s reciprocal tariffs, arguing an “eye for an eye just leaves both people blind.” Kennedy, who serves on the Banking and Budget Committee, ...

AstraZeneca has been busy in recent years pumping up its oncology pipeline via a shopping list of assets and companies. Now, the U.K.-based pharma is overseeing a range of clinical trials to ...